Please join us for a sponsored breakfast presentation by Neurocine Biosciences!

Kendra Davies, PharmD will provide an overview of Tardive dyskinesia, its presentation, and diagnosis. She will educate the audience on how to conduct an AIMS (Abnormal Involuntary Movement Scale) assessment in patients who are initiating or being treated with dopamine receptor blocking agents and how to rate the severity of abnormal movements.